Impaired endothelium-mediated vasodilation in heart failure: Clinical evidence and the potential for therapy

Journal of Cardiac Failure

Volumn 8, Issue 1, 2002, Pages 15-20

  Elkayam, Uri ^a   Khan, Salman ^a   Mehboob, Ather ^a   Ahsan, Nusrat ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTIOXIDANT; ASCORBIC ACID; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; ENALAPRILAT; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; QUINAPRILAT; SILDENAFIL; SPIRONOLACTONE; VASODILATOR AGENT;

ARTICLE; CHRONIC DISEASE; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM INJURY; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HUMAN; LUNG CIRCULATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SURVIVAL; SYMPTOMATOLOGY; VASODILATATION;

EID: 0036167935     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.31910     Document Type: Article

References (55)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. Coronary endothelial function in health and disease
3. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
4. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats
5. Molecular mechanisms and therapeutic strategies related to nitric oxide
6. Maintaining the endothelium: Preventive strategies for vessel integrity
7. What we know and don't know about L-arginine and NO
8. Endothelium dependent vasodilation is attenuated in patients with heart failure
9. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: Role of endothelium derived vasodilating and vasoconstricting factors
10. Endothelial function in chronic congestive heart failure
11. Impaired endothelium mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
12. Regulatory functions of the vascular endothelium
13. Mechanisms and implications of endothelial dysfunction in congestive heart failure
14. Endothelial control of arterial distensibility is impaired in chronic heart failure
15. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy
16. Abnormal coronary blood flow reserve in idiopathic dilated cardiomyopathy is due to impairment of both endothelium-dependent and independent microcirculatory vasodilation
17. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
18. Pulmonary circulatory response to endothelial stimulation in patients with chronic heart failure
19. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure
20. Oxygen free radicals and congestive heart failure
21. Potential sites and changes of superoxide anion production in failing and non-failing explanted human cardiac myocytes
22. Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins
23. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure
24. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
25. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors
26. Endothelial functions and bradykinin in humans
27. Local L-N-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm
28. Mial: Effects of vasoactive peptides on prostacyclin synthesis in man
29. Potentiation of endothelium-dependent relaxation to bradykinin by angiotensin-I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors
30. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects
31. Effect of angiotensin converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure
32. Peripheral vascular remodeling in chronic heart failure: Clinical relevance and new conceptualization of its mechanisms
33. Vascular endothelial cells synthesize nitric oxide from L-arginine
34. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearms in patients with heart failure
35. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
36. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure
37. Attenuation of acetylcholine mediated coronary vasoconstriction with nonvasodilating dose of nitroglycerin in patients with heart failure: Evidence for nitroglycerin induced enhancement of endogenous nitric oxide effect?
38. Does nitroglycerin therapy hit the endothelium?
39. A double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin converting enzyme inhibition
40. Acute type 5 phosphodiasterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure
41. The effect of sprionolactone on morbidity and mortality in patients with severe heart failure
42. Why does spironolactone improve mortality over and above an ACE-inhibitor in chronic heart failure?
43. Aldosterone inhibits nitric oxide synthesis in rat's vascular smooth muscle cells induced by interleukin-1B
44. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
45. Drug-induced conditioning in congestive heart failure
46. Sustained improvement of cardiac function in patients with congestive heart failure after shortterm infusion of dobutamine
47. Conditioning effects of chronic infusions of dobutamine
48. Sustained improvement in flow-mediated vasodilation after short-term administration of dobutamine in patients with severe congestive heart failure
49. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions
50. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow
51. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression
52. Physical training alters the pathogenesis of pacing-induced heart failure through endothelium-mediated mechanisms in awake dogs
53. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure
54. Physical training improves endothelial function in patients with chronic heart failure
55. Training improves endothelium-dependent vasodilation in resistance vessels of patients with heart failure